Joan Stephenson. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » ContraindicationsDiabetes Mellitus/drug therapyDrug LabelingHumansHypoglycemic Agents/adverse effectsHypoglycemic Agents/therapeutic usePioglitazoneRiskThiazolidinediones/adverse effectsThiazolidinediones/therapeutic useUnited StatesUnited States Food and Drug AdministrationUrinary Bladder Neoplasms/epidemiology
Substances: See more » Hypoglycemic AgentsThiazolidinedionesPioglitazone
Year: 2011 PMID: 21750286 DOI: 10.1001/jama.2011.939
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272